Source comparison
Best KPV Dosage for Skin Conditions: Clinical Comparison
Vitiligo (melanocyte preservation) 500 mcg daily 2 mg/mL cream Once daily (SC) or twice daily (topical) Stabilization at 8–12 weeks; repigmentation at 16+ weeks High-dose subcutaneous produces most consistent outcomes. Topical alone shows limited repigmentatio
This comparison does not assign a generated winner or score.
- Vitiligo (melanocyte preservation)
- 500 mcg daily
- 2 mg/mL cream
- Once daily (SC) or twice daily (topical)
- Stabilization at 8–12 weeks; repigmentation at 16+ weeks
- High-dose subcutaneous produces most consistent outcomes. Topical alone shows limited repigmentation
- Psoriasis (plaque reduction)
- 200–300 mcg daily
- 1–2 mg/mL gel
- Twice daily (100–150 mcg per dose SC) or twice daily (topical)
- Plaque thickness reduction at 4–6 weeks
- Lower doses effective for inflammatory suppression. Combine with phototherapy for best results
- Inflammatory dermatoses (general)
- 200 mcg daily
- 1 mg/mL cream
- Once or twice daily
- Erythema reduction within 2–4 weeks
- Conservative dosing minimizes cost while achieving anti-inflammatory threshold
- Localized lesions (eczema, contact dermatitis)
- Not typically used
- 1 mg/mL topical
- Twice daily to affected areas
- Symptom relief within 1–2 weeks
- Topical delivery preferred for localized conditions. Avoids systemic exposure